<html>
<head>PUBMED IDs for GLS2</head>
<body bgcolor='#C5F0F2'><h1>GLS2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/12801632/'>Identification of 9 novel transcripts and two RGSL genes within the hereditary prostate cancer region (HPC1) at 1q25.</a> June 13  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/17669570/'>Increased plasma glutamate by antipsychotic medication and its relationship to glutaminase 1 and 2 genotypes in schizophrenia -- Juntendo University Schizophrenia Projects (JUSP).</a> August 3  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/20351271/'>Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species.</a> May 28  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20378837/'>Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function.</a> May 28  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20729871/'>The role of p53 in cell metabolism.</a> January 5  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20885795/'>A novel statistic for genome-wide interaction analysis.</a> January 5  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22934847/'>Glutaminase isoenzymes as key regulators in metabolic and oxidative stress against cancer.</a> October 23  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22934838/'>SALL4 is a key transcription regulator in normal human hematopoiesis.</a> July 9  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23574722/'>p63 regulates glutaminase 2 expression.</a> December 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23954443/'>Knock-down of glutaminase 2 expression decreases glutathione, NADH, and sensitizes cervical cancer to ionizing radiation.</a> February 25  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24096582/'>Silencing of GLS and overexpression of GLS2 genes cooperate in decreasing the proliferation and viability of glioblastoma cells.</a> June 4  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24121663/'>GLS2 is transcriptionally regulated by p73 and contributes to neuronal differentiation.</a> October 3  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24276018/'>Both GLS silencing and GLS2 overexpression synergize with oxidative stress against proliferation of glioma cells.</a> October 24  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24797434/'>Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma.</a> February 20  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25026281/'>Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25529918/'>Opposing roles of glutaminase isoforms in determining glioblastoma cell phenotype.</a> June 1  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26186940/'>Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.</a> December 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26258493/'>Downregulation of GLS2 in glioblastoma cells is related to DNA hypermethylation but not to the p53 status.</a> August 11  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26581715/'>Glutaminases in slowly proliferating gastroenteropancreatic neuroendocrine neoplasms/tumors (GEP-NETs): Selective overexpression of mRNA coding for the KGA isoform.</a> June 17  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27079415/'>The combination of three molecular markers can be a valuable predictive tool for the prognosis of hepatocellular carcinoma patients.</a> April 22  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27484708/'>The African-specific S47 polymorphism of p53 alters chemosensitivity.</a> August 4  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28526749/'>The origin and evolution of human glutaminases and their atypical C-terminal ankyrin repeats.</a> May 21  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28609101/'>Design, Synthesis, and Evaluation of Thiazolidine-2,4-dione Derivatives as a Novel Class of Glutaminase Inhibitors.</a> June 14  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28614770/'>Transcription factor GATA3 expression is induced by GLS2 overexpression in a glioblastoma cell line but is GLS2-independent in patient-derived glioblastoma.</a> June 15  2017<br></body></html>
